A role for cell adhesion in beryllium-mediated lung disease

Journal of Occupational and Environmental Hygiene

Volumn 6, Issue 12, 2009, Pages 727-731

  Hong Geller, Elizabeth ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Beryllium; Cell adhesion; Host immune response

Indexed keywords

BETA2 INTEGRIN; CHEMOKINE; INTERCELLULAR ADHESION MOLECULE 1;

BERYLLIOSIS; BLOOD CELL; CELL ADHESION; CELL INTERACTION; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LUNG ALVEOLUS EPITHELIUM; MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

BERYLLIOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL MOVEMENT; CHEMOKINES; HUMANS; IMMUNITY, CELLULAR; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MODELS, IMMUNOLOGICAL; UP-REGULATION;

EID: 70449602020     PISSN: 15459624     EISSN: 15459632     Source Type: Journal    
DOI: 10.1080/15459620903011160     Document Type: Review

References (15)

1. Fontenot, A.P., and L.A. Maier: Genetic susceptibility and immunemediated destruction in beryllium-induced disease. Trends Immunol. 26:543-549 (2005).
2. Samuel, G., and L.A. Maier: Immunology of chronic beryllium disease. Curr. Opin. Allergy Clin. Immunol. 8:126-134 (2008).
3. Scott, B., T. McCleskey, A. Chaudhary, E. Hong-Geller, and S. Gnanakaran: The bioinorganic chemistry and associated immunology of chronic beryllium disease. Chem. Commun. 25:2837-2847 (2008).
4. Kreiss, K., S. Wasserman, M. Mroz, and L.S. Newman: Beryllium disease screening in the ceramics industry: Blood test performance and exposure-disease relations. J. Occup. Med. 35:267-274 (1993).
5. Kreiss, K., M. Mroz, B. Zhen, J. Martyny, and L.S. Newman: Epidemiology of beryllium sensitization and disease in nuclear workers. Am. Rev. Respir. Dis. 148:985-991 (1993).
6. Kreiss, K.,M.Mroz, L. Newman, J.Martyny, and B. Zhen: Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am. J. Ind. Med. 30:16-25 (1996).
7. Infante, P., and L. Newman: Beryllium exposure and chronic beryllium disease. Lancet 363(9407):415-416 (2004).
8. Kelleher, P., J. Martyny, M. Mroz, et al.: Beryllium particulate exposure and disease relations in a beryllium machining plant. J. Occup. Environ. Med. 43:238-249 (2001). (Pubitemid 32238503)
9. Tinkle, S.S., L.A. Kittle, B.A. Schumacher, and L.S. Newman: Beryllium induces IL-2 and IFN-gamma in berylliosis. J. Immunol. 158:518-526 (1997).
10. Tinkle, S.S., and L. S. Newman: Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 156:1884-1891 (1997).
11. Pilewski, J., and S. Albelda: Adhesion molecules in the lung. An overview. Am. Rev. Respir. Dis. 148:S31-S37 (1993).
12. Sawyer, R., D. Doherty, B. Schumacher, and L. Newman: Berylliumstimulated in vitromigration of peripheral blood lymphocytes. Toxicology 138:155-163 (1999).
13. Richeldi, L., R. Sorrentino, and C. Saltini: HLA-DPB1 glutamate 69: A genetic marker of beryllium disease. Science 262:242-244 (1993).
14. Sato, H., L. Silveira, T. Fingerlin, et al.: TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J. Allergy Clin. Immunol. 119:687-696 (2007).
15. Jonth, A., L. Silveira, T. Fingerlin, et al.: TGF-beta1 variants in chronic beryllium disease and sarcoidosis. J. Immunol. 179:4255-4262 (2007).